GENTAUR Molecular Products.
Monoclonal Antibody, ELISA Kit, Polyclonal Antibody, Recombinant/Purified Protein.
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
GENTAUR U.S.A Genprice Inc 6017 Snell Ave, Ste 357, SanJose, CA 95123
Tel (408) 780-0908, Fax (408) 780-0908, sales@genprice.com
Index / Exbio / CD22 / Product Detail : 1A-265-T100 CD22
Related keywords:
Sep
27th
#1A-265-T100 CD22
| Price : | 346 | EUR |
| 393 | USD | |
| 268 | GBP | |
| 1456 | Zloty | |
| 46377 | JPY | |
| 2673 | NOK | |
| 2864 | SEK | |
| 392 | CHF |
Product name : CD22
Catalog number : 1A-265-T100
Quantity: 100 tests
Availability: Yes
Supplier name : Exbio
Data sheet: Ask more or other datasheet now !
Contact us about this product :
Our team will respond you as soon as possible !
GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45
Fax 0032 16 50 90 45
info@gentaur.com | Gentaur
GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur
GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50
Fax 01 43 25 01 60
RCS Paris B 484 237 888
SIRET 48423788800017
BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG
france@gentaur.com | Gentaur
GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88
Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur
GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com
Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123
GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel: 0208-080893 Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62 SWIFT RABONL2U
GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur
ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF
GENTAUR Poland Sp. z o.o.
ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX 058 710 33 48
poland@gentaur.com | Gentaur
Other countries
Österreich +43720880899
Canada Montreal +15149077481
Ceská republika Praha +420246019719
Danmark +4569918806
Finland Helsset +358942419041
Magyarország Budapest +3619980547
Ireland Dublin+35316526556
Luxembourg+35220880274
Norge Oslo+4721031366
Sverige Stockholm+46852503438
Schweiz Züri+41435006251
US New York+17185132983
GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo
Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur
Gentaurpub
WP1025: B Cell Receptor Signaling Pathway
WP1144: B Cell Receptor Signaling Pathway
WP274: B Cell Receptor Signaling Pathway
WP285: B Cell Receptor Signaling Pathway
WP794: B Cell Receptor Signaling Pathway
WP908: B Cell Receptor Signaling Pathway
Related Genes :
[Cd22 Lyb-8 Siglec2] B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)
[CD22 SIGLEC2] B-cell receptor CD22 (B-lymphocyte cell adhesion molecule) (BL-CAM) (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (T-cell surface antigen Leu-14) (CD antigen CD22)
[CD22 SIGLEC2] B-cell receptor CD22 (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (CD antigen CD22) (Fragment)
[CD22 SIGLEC2] B-cell receptor CD22 (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (CD antigen CD22) (Fragment)
[CD22 SIGLEC2] B-cell receptor CD22 (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (CD antigen CD22) (Fragment)
[CD22 SIGLEC2] B-cell receptor CD22 (Sialic acid-binding Ig-like lectin 2) (Siglec-2) (CD antigen CD22) (Fragment)
[Lyn] Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)
[LYN JTK8] Tyrosine-protein kinase Lyn (EC 2.7.10.2) (Lck/Yes-related novel protein tyrosine kinase) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)
[Cd22 Cd22_predicted rCG_53799] CD22 antigen (Predicted) (Protein Cd22)
[Lyn] Tyrosine-protein kinase Lyn (EC 2.7.10.2) (V-yes-1 Yamaguchi sarcoma viral related oncogene homolog) (p53Lyn) (p56Lyn)
[Cd22] B-cell receptor CD22
[CD22] CD22 antigen (CD22 molecule)
[CD22_2 CD22_0 g.13266 g.13273] B-cell receptor CD22
[CD22] B-cell receptor CD22
[PTPN6 HCP PTP1C] Tyrosine-protein phosphatase non-receptor type 6 (EC 3.1.3.48) (Hematopoietic cell protein-tyrosine phosphatase) (Protein-tyrosine phosphatase 1C) (PTP-1C) (Protein-tyrosine phosphatase SHP-1) (SH-PTP1)
[CD22] B-cell receptor CD22
[CD22] B-cell receptor CD22
[rbcL] Ribulose bisphosphate carboxylase large chain (EC 4.1.1.39) (Fragment)
[SYK] Tyrosine-protein kinase SYK (EC 2.7.10.2) (Spleen tyrosine kinase) (p72-Syk)
[Cd22] Cd22 protein
[PLCG1 PLC1] 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 (EC 3.1.4.11) (PLC-148) (Phosphoinositide phospholipase C-gamma-1) (Phospholipase C-II) (PLC-II) (Phospholipase C-gamma-1) (PLC-gamma-1)
[CD22] B-cell receptor CD22 isoform 1
[CD22] CD22 molecule
[CD22] CD22 protein
[CD22] B-cell receptor CD22
[CD22_4 c1_g1_i17] B-cell receptor CD22
[CD22_11 c1_g1_i11] B-cell receptor CD22
[CD22_3 c1_g1_i21] B-cell receptor CD22
[CD22_6 c1_g1_i6] B-cell receptor CD22
[CD22] B-cell receptor CD22
Bibliography :
[27663753] Biotherapies in systemic lupus erythematosus: New targets.
[27624073] Reduced immune response to polymeric micelles coating sialic acids.
[27607436] Mixed Phenotype Acute Leukemia with t(12;17)(p13;q21)/TAF15-ZNF384 and Other Chromosome Abnormalities.
[27601593] Phase I study of the anti-CD22 antibody-drug conjugate pinatuzumab vedotin with/without rituximab in patients with relapsed/refractory B-cell non-Hodgkin's lymphoma.
[27598971] A novel flow cytometric assay for detection of residual disease in patients with B-lymphoblastic leukemia/lymphoma post anti-CD19 therapy.
[27598855] Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results from the Phase 3, Randomized, Double-blind, Placebo-controlled Trials, EMBODY™ 1 and EMBODY™ 2.
[27559941] Development-associated immunophenotypes reveal the heterogeneous and individualized early responses of adult B-acute lymphoblastic leukemia.
[27554819] Exploiting CD22 on antigen-specific B cells to prevent allergy to the major peanut allergen Ara h 2.
[27524505] Preclinical evaluation of a diabody-based (177)Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model.
[27521873] New monoclonal antibodies for the treatment of acute lymphoblastic leukemia.
Share this page:
Enter catalog number :
Favorites Pages:
No Favorits